Patents by Inventor Stefan Gattenlohner

Stefan Gattenlohner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunotoxin derived from a recombinant human autoantibody and method of using thereof
    Patent number: 8114969
    Abstract: The invention is directed to an immunotoxin directed at fetal AchR, wherein the immunotoxin may comprises a human Fab fragment based on a human autoantibody or human combinatorial CDNA library and may be a pseudomonas exotoxin A-based single chain Fv IT (35-scFV-ETA). The invention is further directed to method of treating a patient with soft tissue tumor comprising the step of exposing the patient to the immunotoxin of the invention.
    Type: Grant
    Filed: September 28, 2004
    Date of Patent: February 14, 2012
    Assignee: ISIS Innovation, Ltd.
    Inventors: Angela Vincent, Alexander Marx, Stefan Gattenlohner
  • Immunotoxin derived from a recombinant human autoantibody and method of using thereof
    Publication number: 20060013809
    Abstract: The invention is directed to an immunotoxin directed at fetal AchR, wherein the immunotoxin may comprises a human Fab fragment based on a human autoantibody or human combinatorial cDNA library and may be a pseudomonas exotoxin A-based single chain Fv IT (35-scFV-ETA). The invention is further directed to method of treating a patient with soft tissue tumour comprising the step of exposing the patient to the immunotoxin of the invention.
    Type: Application
    Filed: March 15, 2005
    Publication date: January 19, 2006
    Inventors: Angela Vincent, Alexander Marx, Stefan Gattenlohner